Literature DB >> 11817105

Animal model of diabetic nephropathy.

T Yokozawa1, T Nakagawa, K Wakaki, F Koizumi.   

Abstract

Injection of subtotally nephrectomized rats with streptozotocin produced metabolic abnormalities resembling diabetic nephropathy in humans. These abnormalities were hyperglycemia, hypoinsulinemia, azotemia, hypertriglyceridemia and hypercholesterolemia, accompanied with an increase in glycosylated protein. Extraordinary changes in the urinary excretion of glucose and protein were also observed in rats that received streptozotocin treatment after subtotal nephrectomy. In addition, the level of creatinine clearance was significantly decreased. The pathological findings in the kidney of these rats revealed lesions of the glomerular capillary loops, mesangial area and Bowman's capsule. Coagulation was also found in the glomerular capillaries. Our results suggest that this rat model would be useful for studies of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11817105     DOI: 10.1078/0940-2993-00203

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  8 in total

1.  Establishment of a diabetic mouse model with progressive diabetic nephropathy.

Authors:  Akari Inada; Kojiro Nagai; Hidenori Arai; Jun-ichi Miyazaki; Keiko Nomura; Hiroshi Kanamori; Shinya Toyokuni; Yuichiro Yamada; Susan Bonner-Weir; Gordon C Weir; Atsushi Fukatsu; Yutaka Seino
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

2.  Protective effect of herbomineral formulation (Dolabi) on early diabetic nephropathy in streptozotocin-induced diabetic rats.

Authors:  Mirza A Baig; Vikas B Gawali; Rajesh R Patil; Suresh R Naik
Journal:  J Nat Med       Date:  2011-11-25       Impact factor: 2.343

3.  Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathy.

Authors:  Li-Hao Chen; Bailey Stead; Suzanne L Advani; Noreen Yaqoob; Kerri Thai; M Golam Kabir; Darren A Yuen; Kim A Connelly; Richard E Gilbert; Andrew Advani
Journal:  Nephron Extra       Date:  2012-05-12

4.  Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice.

Authors:  Sung-Hsun Yu; Navneet Kumar Dubey; Wei-Shan Li; Ming-Che Liu; Han-Sun Chiang; Sy-Jye Leu; Ying-Hua Shieh; Feng-Chou Tsai; Win-Ping Deng
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

Review 5.  Animal Models of Diabetes-Associated Renal Injury.

Authors:  Zahra Samadi Noshahr; Hossein Salmani; Abolfazl Khajavi Rad; Amirhossein Sahebkar
Journal:  J Diabetes Res       Date:  2020-05-20       Impact factor: 4.011

Review 6.  Rodent animal models: from mild to advanced stages of diabetic nephropathy.

Authors:  Manpreet Kaur; Onkar Bedi; Shilpi Sachdeva; B V K Krishna Reddy; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2014-08-23       Impact factor: 4.473

7.  Renoprotective effect of JinQi-JiangTang tablet on high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats.

Authors:  Bingjie Jiang; Zhuo Qu; Yue Gu; Xia Li; Juan Wang; Jingze Zhang; Shuli Man; Changxiao Liu; Wenyuan Gao
Journal:  RSC Adv       Date:  2018-12-14       Impact factor: 4.036

8.  Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy.

Authors:  Ning Yan; Li Wen; Rui Peng; Hongmei Li; Handeng Liu; Huimin Peng; Yan Sun; Tianhui Wu; Lei Chen; Qingrui Duan; Yixuan Sun; Qin Zhou; Lijiang Wei; Zheng Zhang
Journal:  J Diabetes Res       Date:  2016-06-30       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.